Final hours! Save up to 50% OFF InvestingProCLAIM SALE

Aurora Cannabis (TSX:ACB) Just Won a Huge Supply Contract That Could Change Everything

Published 2019-07-22, 10:19 a/m
© Reuters.
WMB
-

Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) is a cannabis export powerhouse. Shipping weed everywhere from Germany to the U.K., it has become a truly international company.

Currently, Aurora’s international operations reach 24 countries, and with 40 nations in total having legalized medical pot, that reach could get even wider.

Recently, Aurora’s international operations got a big boost when it was announced that the company had won a tender to supply 400 kilograms of cannabis to Italy over the course of two years.

As the sole winner of the contract, Aurora will have a dominant position in Italy’s emerging cannabis market. This bears well for Aurora’s future, as it shows that the company is establishing a strong position in one of the world’s fastest-growing cannabis markets.

Why the European market matters so much As Sean Williams (NYSE:WMB) reported in a recent fool.com piece, 40 countries worldwide have legalized medical cannabis, with a significant number of those are in Europe. Medical marijuana is a booming business in Germany, the U.K. and Denmark, with many more EU countries soon to follow.

As medical pot is so widely accepted in Europe, the continent has become one of the most lucrative cannabis markets in the world: according to consultancy.eu, the cannabis market in the region is worth €16.6 billion a year.

This means that the more a Canadian company expands into EU markets, the greater its potential revenue growth.

Illegal pot gets cheaper while legal weed gets more expensive A massive accessible market isn’t the only reason why the EU is so important to Canadian pot producers — a relative lack of growth potential at home is another.

Although the Canadian marijuana market was bolstered by the legalization of adult-use sales last October, there are signs that the recreational weed market has already peaked.

In a recent quarter, Aphria saw its recreational sales decline 35%, while Aurora’s recreational sales growth was tepid compared to international medical sales growth.

One of the reasons for this is the fact that black market pot keeps getting cheaper, while the legal stuff becomes more expensive. According to a recent StatsCan report, street prices have fallen from $6.23 to $5.93 per gram, while in-store prices have risen from $10.21 to $10.65.

This means that black market cannabis is far more affordable than the legal equivalent, providing customers with a strong incentive to choose dealers over stores.

Foolish takeaway Aurora Cannabis has long been one of the largest and fastest-growing weed companies. With its massive international presence and a huge share of the domestic adult-use market, it’s a juggernaut in every sense of the word.

Now, with an exclusive Italian supply deal in place, it’s ready to move 400 kilograms worth of weed in one of the EU’s most lucrative markets. If there was ever a good time to consider investing in Aurora over its competitors, now would be it.

Fool contributor Andrew Button has no position in any of the stocks mentioned.

The Motley Fool’s purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool Canada’s free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. Motley Fool Canada 2019

This Article Was First Published on The Motley Fool

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.